Renal status among patients using metformin in a primary care setting

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 922-924

  Kennedy, Laurence ^a   Herman, William H ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CREATININE BLOOD LEVEL; FEMALE; FOOD AND DRUG ADMINISTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE;

ADOLESCENT; ADULT; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY; METFORMIN; PHYSICIANS, FAMILY;

EID: 15944423983     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.922     Document Type: Article

References (12)

1. Glucophage/Glucophage XR [package insert]. Princeton, NJ, Bristol-Myers Squibb, 2004
2. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA: Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265-266, 1998
3. Misbin RI: The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 27:1791-1793, 2004
4. Stacpoole PW: Metformin and lactic acidosis: guilt by association? Diabetes Care 21:1587-1588, 1998
5. Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD, for the DARTS/ MEMO Collaboration: Contraindications to metformin therapy in patients with type 2 diabetes: a population-based study of adherence to prescribing guidelines. Diabet Med 18:483-488, 2001
6. Howlett HC, Bailey CJ: A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 20:489-503, 1999
7. Horlen C, Malone R, Bryant B, Dennis B, Carey T, Pignone M, Rothman R: Frequency of inappropriate metformin prescriptions. JAMA 287:2504-2505, 2002
8. Sulkin TV, Bosman D, Krentz AJ: Contra-indications to metformin therapy in patients with NIDDM. Diabetes Care 20:925-928, 1997
9. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH: Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 162:434-437, 2002
10. National Kidney Foundation: National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Available from http://www.kidney.org/professionals/ doqi/kdoqi/p5_lab_g4.htm. Accessed 13 December 2004
11. Ishida K, Ishida H, Narita M, Sairenchi T, Saito Y, Fukutomi H, Takahashi H, Yamagata K, Koyama A: Factors affecting renal function in 119,985 adults over three years. Q J Med 94:541-550, 2001
12. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 84:1053-1060, 1988